brochure
Drug Metabolism and Pharmacokinetics (DMPK) Services
At Frontage Europe, our scientific staff applies state-of-the-art techniques and best-in-class approaches to generate data for critical milestones and decision-making during drug discovery and development.
Resources to Consider
poster
Quantitative Assessment of mRNA Drug Biological Activity by...
Biological activity of mRNA drugs, historically assessed via animal study, is critical to ...
webinar
Cost Effective and Efficient Progression of Lead Drug Candidates to...
Hosted by ISSX, Frontage's own Dr John Kapeghian discusses the "Cost Effective and Efficie...
poster
Development of Stable Nanoemulsion Formulation as an Ophthalmic Drug...
This study is aimed at developing a Nanoemulsion formulation of a poorly water-soluble and...
panel-discussion
Challenges of Global Drug Development
This discussion focuses on the challenges of global drug development and the long-term imp...
poster
Validation of a 384 gene hybridization capture-based pharmacogenomics...
Frontage has developed a next-generation sequencing (NGS)-based method to rapidly deter...
fact-sheet
Immunoassays for Drug Discovery
Frontage supports early drug discovery with various immunoassays for proteins and therapeu...
fact-sheet
Global Drug Discovery Services Overview
Frontage’s discovery team is comprised of experienced medical chemists, biologists,and D...
panel-discussion
Utilizing Ligand Binding Assays (LBA) and Critical Reagents for Drug...
Critical reagents – the key components used in LBA – are central to ensuring the consi...
case-study
Preclinical Drug Screening Using Gyrolab
In this case study, we share how Frontage used Gyrolab to conduct a Sponsor's study effici...
